Abstract mRNA vaccines have gained popularity over the last decade as a versatile tool for
developing novel therapeutics. The recent success of coronavirus disease (COVID-19) …

Messenger ribonucleic acid (mRNA) vaccines are a relatively new class of vaccines that
have shown great promise in the immunotherapy of a wide variety of infectious diseases and …

The COVID-19 pandemic has elevated mRNA vaccines to global recognition due to their
unprecedented success rate in protecting against a deadly virus. This international success …

Years of research exploring mRNA vaccines for cancer treatment in preclinical and clinical
trials have set the stage for the rapid development of mRNA vaccines during the COVID-19 …

Abstract mRNA vaccines have become a promising platform for cancer immunotherapy.
During vaccination, naked or vehicle loaded mRNA vaccines efficiently express tumor …

Patients exhibit good tolerance to messenger ribonucleic acid (mRNA) vaccines, and the
choice of encoded molecules is flexible and diverse. These vaccines can be engineered to …

Both infectious viral diseases and cancer have historically been some of the most common
causes of death worldwide. The COVID-19 pandemic is a decidedly relevant example of the …

The corresponding mRNA vaccines Comirnaty (BNT162b2) and Spikevax (mRNA-1273)
have been authorized for emergency use since the COVID-19 outbreak. Most clinical …

Since the successful application of messenger RNA (mRNA) vaccines in preventing COVID-
19, researchers have been striving to develop mRNA vaccines for clinical use, including …

Recently, mRNA vaccines have become a significant type of therapeutic and have created
new fields in the biopharmaceutical industry. mRNA vaccines are promising next-generation …